Journal of Colloid and Interface Science, Vol.510, 345-356, 2018
A prominent anchoring effect on the kinetic control of drug release from mesoporous silica nanoparticles (MSNs)
This work demonstrated kinetically controlled release of model drugs (ibuprofen, FITC) from well tailored mesoporous silica nanoparticles (MSNs) depending on the surface charges and molecular sizes of the drugs. The molecular interactions between entrapped drugs and the pore walls of MSNs controlled the release of the drugs through the pore channels of MSNs. Also, polydopamine (PDA) layer-coated MSNs (MSNs@PDA) was quite effective to retard the release of large FITC, in contrast to a slight retardation effect on relatively small Ibuprofen. Of all things, FITC (Fluorescein isothiocyanate)-labeled APTMS (3-ami nopropyltrimethoxysilane) (APTMS-FITC conjugates) grafted onto the MSNs generate a pinch-effect on the pore channel (so-called a prominent anchoring effect), which was highly effective in trapping (or blocking) drug molecules at the pore mouth of the MSNs. The anchored APTMS-FITC conjugates provided not only tortuous pathways to the diffusing molecules, but also sustained release of the ibuprofen over a long period of time (similar to 7 days). The fast release kinetics was predicted by an exponential equation based on Fick's law, while the slow release kinetics was predicted by Higuchi model. (C) 2017 Elsevier Inc. All rights reserved.
Keywords:Anchoring effect;FITC-APTMS conjugates;Polydopamine;Release kinetics;Controlled release;MSNs